{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:17:57Z","timestamp":1779160677193,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00380-024-02447-w","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T04:01:31Z","timestamp":1722225691000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of cardiac amyloidosis in atrial fibrillation: a CMR study prior to catheter ablation"],"prefix":"10.1007","volume":"40","author":[{"given":"Mai","family":"Azuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7545-0669","authenticated-orcid":false,"given":"Shingo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shungo","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryouya","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"issue":"1","key":"2447_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR (2024) 2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149(1):e1\u2013e156","journal-title":"Circulation"},{"issue":"5","key":"2447_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, B\u00e4nsch D (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417\u2013427","journal-title":"N Engl J Med"},{"issue":"4","key":"2447_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaccao.2021.07.010","volume":"3","author":"J Hartnett","year":"2021","unstructured":"Hartnett J, Jaber W, Maurer M, Sperry B, Hanna M, Collier P, Patel DR, Wazni OM, Donnellan E (2021) Electrophysiological manifestations of cardiac amyloidosis: JACC: cardiooncology state-of-the-art review. JACC CardioOncol 3(4):506\u2013515","journal-title":"JACC CardioOncol"},{"issue":"11","key":"2447_CR4","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.3390\/biomedicines10112888","volume":"10","author":"A Argir\u00f2","year":"2022","unstructured":"Argir\u00f2 A, Del Franco A, Mazzoni C, Allinovi M, Tomberli A, Tarquini R, Di Mario C, Perfetto F, Cappelli F, Zampieri M (2022) Arrhythmic burden in cardiac amyloidosis: what we know and what we do not. Biomedicines 10(11):2888","journal-title":"Biomedicines"},{"issue":"8","key":"2447_CR5","first-page":"337","volume":"10","author":"A Briasoulis","year":"2023","unstructured":"Briasoulis A, Kourek C, Papamichail A, Loritis K, Bampatsias D, Repasos E, Xanthopoulos A, Tsougos E, Paraskevaidis I (2023) Arrhythmias in patients with cardiac amyloidosis: a comprehensive review on clinical management and devices. J Cardiovasc Dev Dis 10(8):337","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"2447_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","volume":"18","author":"P Haaf","year":"2016","unstructured":"Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18(1):89","journal-title":"J Cardiovasc Magn Reson"},{"issue":"15","key":"2447_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/eurheartj\/ehi258","volume":"26","author":"H Mahrholdt","year":"2005","unstructured":"Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26(15):1461\u20131474","journal-title":"Eur Heart J"},{"issue":"2","key":"2447_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcmg.2023.10.010","volume":"17","author":"L Alwan","year":"2023","unstructured":"Alwan L, Benz DC, Cuddy SAM, Dobner S, Shiri I, Caobelli F, Bernhard B, St\u00e4mpfli SF, Eberli F, Reyes M, Kwong RY, Falk RH, Dorbala S, Gr\u00e4ni C (2023) Current and evolving multimodality cardiac imaging in managing transthyretin amyloid cardiomyopathy. JACC Cardiovasc Imag 17(2):195\u2013211","journal-title":"JACC Cardiovasc Imag"},{"issue":"6","key":"2447_CR9","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","volume":"13","author":"JA Pan","year":"2020","unstructured":"Pan JA, Kerwin MJ, Salerno M (2020) Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis. JACC Cardiovasc Imag 13(6):1299\u20131310","journal-title":"JACC Cardiovasc Imag"},{"issue":"16","key":"2447_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132(16):1570\u20131579","journal-title":"Circulation"},{"issue":"37","key":"2447_CR11","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP (2023) 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 44(37):3503\u20133626","journal-title":"Eur Heart J"},{"issue":"11","key":"2447_CR12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016","journal-title":"N Engl J Med"},{"issue":"4","key":"2447_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1253\/circj.CJ-22-0683","volume":"87","author":"Y Ichikawa","year":"2023","unstructured":"Ichikawa Y, Oota E, Odajima S, Kintsu M, Todo S, Takeuchi K, Yamauchi Y, Shiraki H, Yamashita K, Fukuda T, Hisamatsu E, Hirata KI, Tanaka H (2023) Impact of tafamidis on echocardiographic cardiac function of patients with transthyretin cardiac amyloidosis. Circ J 87(4):508\u2013516","journal-title":"Circ J"},{"key":"2447_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-024-02408-3","author":"A Achten","year":"2024","unstructured":"Achten A, van Empel VPM, Weerts J, Mourmans S, Beckers-Wesche F, Spanjers M, Gingele A, Brunner-La Rocca HP, Sanders-van Wijk S, Knackstedt C (2024) Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years. Heart Vessels. https:\/\/doi.org\/10.1007\/s00380-024-02408-3","journal-title":"Heart Vessels"},{"issue":"4","key":"2447_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00380-023-02342-w","volume":"39","author":"A Shibata","year":"2024","unstructured":"Shibata A, Izumiya Y, Yoshida T, Tanihata A, Yamaguchi Y, Kitada R, Fukuda D (2024) Elevation of end-tidal CO(2) during exercise is attenuated in patients with cardiac amyloidosis. Heart Vessels 39(4):340\u2013348","journal-title":"Heart Vessels"},{"key":"2447_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-024-02396-4","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Yuan H, Qu H (2024) Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis. Heart Vessels. https:\/\/doi.org\/10.1007\/s00380-024-02396-4","journal-title":"Heart Vessels"},{"issue":"7","key":"2447_CR17","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans A, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart R, Verberne HJ, Bourque JM (2021) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imag 14(7):e000029","journal-title":"Circ Cardiovasc Imag"},{"issue":"9","key":"2447_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","volume":"8","author":"VS Hahn","year":"2020","unstructured":"Hahn VS, Yanek LR, Vaishnav J, Ying W, Vaidya D, Lee YZJ, Riley SJ, Subramanya V, Brown EE, Hopkins CD, Ononogbu S, Perzel Mandell K, Halushka MK, Steenbergen C Jr, Rosenberg AZ, Tedford RJ, Judge DP, Shah SJ, Russell SD, Kass DA, Sharma K (2020) Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis. JACC Heart Fail 8(9):712\u2013724","journal-title":"JACC Heart Fail"},{"issue":"38","key":"2447_CR19","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Casta\u00f1o","year":"2017","unstructured":"Casta\u00f1o A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T, George I, Kodali S, Leon MB, Hahn R, Bokhari S, Maurer MS (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879\u20132887","journal-title":"Eur Heart J"},{"key":"2447_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102172","volume":"63","author":"J Wang","year":"2023","unstructured":"Wang J, Chen H, Tang Z, Zhang J, Xu Y, Wan K, Hussain K, Gkoutos GV, Han Y, Chen Y (2023) Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis. EClinicalMedicine 63:102172","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2447_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","volume":"140","author":"T Lane","year":"2019","unstructured":"Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, Rowczenio DM, Gilbertson JA, Hutt DF, Rezk T, Strehina SG, Caringal-Galima J, Manwani R, Sharpley FA, Wechalekar AD, Lachmann HJ, Mahmood S, Sachchithanantham S, Drage EPS, Jenner HD, McDonald R, Bertolli O, Calleja A, Hawkins PN, Gillmore JD (2019) Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation 140(1):16\u201326","journal-title":"Circulation"},{"issue":"7","key":"2447_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1253\/circj.CJ-21-0965","volume":"86","author":"Y Ochi","year":"2022","unstructured":"Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H (2022) Early experience of tafamidis treatment in japanese patients with wild-type transthyretin cardiac amyloidosis from the kochi amyloidosis cohort. Circ J 86(7):1121\u20131128","journal-title":"Circ J"},{"issue":"6","key":"2447_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ehjci\/jeab226","volume":"23","author":"R Rettl","year":"2022","unstructured":"Rettl R, Mann C, Duca F, Dachs TM, Binder C, Ligios LC, Schrutka L, Dalos D, Koschutnik M, Don\u00e0 C, Kammerlander A, Beitzke D, Loewe C, Charwat-Resl S, Hengstenberg C, Kastner J, Eslam RB, Bonderman D (2022) Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy. Eur Heart J Cardiovasc Imag 23(6):767\u2013780","journal-title":"Eur Heart J Cardiovasc Imag"},{"issue":"3","key":"2447_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2303765","volume":"389","author":"P Garcia-Pavia","year":"2023","unstructured":"Garcia-Pavia P, Aus dem Siepen F, Donal E, Lairez O, van der Meer P, Kristen AV, Mercuri MF, Michalon A, Frost RJA, Grimm J, Nitsch RM, Hock C, Kahr PC, Damy T (2023) Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid. N Engl J Med 389(3):239\u2013250","journal-title":"N Engl J Med"},{"issue":"4","key":"2447_CR25","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/ehf2.14380","volume":"10","author":"S Takashio","year":"2023","unstructured":"Takashio S, Morioka M, Ishii M, Morikawa K, Hirakawa K, Hanatani S, Oike F, Usuku H, Kidoh M, Oda S, Yamamoto E, Matsushita K, Ueda M, Tsujita K (2023) Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy. ESC Heart Fail 10(4):2319\u20132329","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2447_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-023-02824-0","volume":"18","author":"CH Tsai","year":"2023","unstructured":"Tsai CH, Chao CC, Hsieh ST, Yu AL, Wu YA, Cheng MF, Lee MJ, Chou CH, Shun CT, Hsueh HW, Jyh-Ming Juang J, Tseng PH, Su MY, Lin YH (2023) Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study. Orphanet J Rare Dis 18(1):289","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2447_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol 79(4):319\u2013328","journal-title":"Am J Hematol"},{"issue":"5","key":"2447_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jcmg.2023.10.008","volume":"17","author":"S Kato","year":"2023","unstructured":"Kato S, Misumi Y, Horita N, Yamamoto K, Utsunomiya D (2023) Clinical utility of computed tomography-derived myocardial extracellular volume fraction: a systematic review and meta-analysis. JACC Cardiovasc Imaging 17(5):516\u2013528","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"2447_CR29","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1007\/s00330-023-09872-x","volume":"33","author":"H Zhang","year":"2023","unstructured":"Zhang H, Guo H, Liu G, Wu C, Ma Y, Li S, Zheng Y, Zhang J (2023) CT for the evaluation of myocardial extracellular volume with MRI as reference: a systematic review and meta-analysis. Eur Radiol 33(12):8464\u20138476","journal-title":"Eur Radiol"},{"issue":"3","key":"2447_CR30","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220542","volume":"306","author":"M Kidoh","year":"2023","unstructured":"Kidoh M, Oda S, Takashio S, Hirakawa K, Kawano Y, Shiraishi S, Hayashi H, Nakaura T, Nagayama Y, Funama Y, Ueda M, Tsujita K, Hirai T (2023) CT extracellular volume fraction versus myocardium-to-lumen signal ratio for cardiac amyloidosis. Radiology 306(3):e220542","journal-title":"Radiology"},{"issue":"7","key":"2447_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1253\/circj.CJ-23-0948","volume":"88","author":"H Yamasaki","year":"2024","unstructured":"Yamasaki H, Kondo H, Shiroo T, Iwata N, Masuda T, Makita T, Iwabuchi Y, Tanazawa K, Takahashi M, Ono Y, Ogawa N, Harada T, Mitarai K, Yamauchi S, Takano M, Kodama N, Hirota K, Miyoshi M, Yonezu K, Tawara K, Abe I, Saito S, Fukui A, Fukuda T, Akioka H, Shinohara T, Akiyoshi K, Teshima Y, Yufu K, Daa T, Matsubara E, Asayama Y, Ueda M, Takahashi N (2024) Efficacy of computed tomography-based evaluation of myocardial extracellular volume combined with red flags for early screening of concealed cardiac amyloidosis in patients with atrial fibrillation. Circ J 88(7):1167\u20131175","journal-title":"Circ J"},{"issue":"6","key":"2447_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/europace\/euae155","volume":"26","author":"H Kanazawa","year":"2024","unstructured":"Kanazawa H, Takashio S, Hoshiyama T, Ito M, Kaneko S, Kiyama T, Kawahara Y, Sumi H, Tsuruta Y, Kuyama N, Hirakawa K, Ishii M, Tabata N, Yamanaga K, Fujisue K, Hanatani S, Sueta D, Arima Y, Araki S, Matsuzawa Y, Usuku H, Nakamura T, Yamamoto E, Soejima H, Matsushita K, Tsujita K (2024) Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia. Europace 26(6):155","journal-title":"Europace"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02447-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02447-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02447-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T03:19:08Z","timestamp":1737947948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02447-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2447"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02447-w","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest regarding this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}